| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/22/1999 | CA2307929A1 Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors |
| 04/22/1999 | CA2306459A1 Compositions for controlling bacterial colonization |
| 04/22/1999 | CA2306453A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 04/22/1999 | CA2306451A1 Methods and compositions for detecting hepatitis e virus |
| 04/22/1999 | CA2306276A1 Pharmaceutically active compound and methods of use |
| 04/22/1999 | CA2306062A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 04/22/1999 | CA2305499A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors |
| 04/21/1999 | EP0909768A2 Process for removing bile salts from a patient and alkylated compositions therefor |
| 04/21/1999 | EP0909272A1 Helicobacter pylori adhesin binding group antigen |
| 04/21/1999 | EP0793641B1 Metalloproteinase inhibitors |
| 04/21/1999 | CN1214636A Photpheresis treatment of chronic HCV infections |
| 04/21/1999 | CN1214339A Pyrazole derivatives, their preparation and their use in pharmaceuticals |
| 04/21/1999 | CN1214244A Use of rifaximin and of pharmaceutical compositions containing it in treatment of diarrhoea from cryptosporidiosis |
| 04/20/1999 | US5895648 Two species of bacteria, oligosaccharides dispersed in ingestible natural product |
| 04/20/1999 | CA2250664A1 Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals |
| 04/20/1999 | CA2124990C Pharmaceutical agents for treatment of emesis |
| 04/15/1999 | WO1999018188A1 Feed product |
| 04/15/1999 | WO1999018128A1 Fibroblast growth factor with hepatocyte proliferation activity |
| 04/15/1999 | WO1999018120A1 Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/15/1999 | WO1999018076A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/15/1999 | WO1999018074A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | WO1999018070A1 Novel vitamin d analogues |
| 04/15/1999 | WO1999017800A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | WO1999017790A1 PEPTIDE-CONTAINING α-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 04/15/1999 | WO1999017787A2 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 04/15/1999 | WO1999017775A1 QUINOLINE-CONTAINING α-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 04/15/1999 | WO1999017773A1 Compounds and methods |
| 04/15/1999 | WO1999017772A1 5ht4 agonists and antagonists |
| 04/15/1999 | WO1999017770A1 Indeno[1,2-c]pyrazole derivatives for inhibiting tyrosine kinase activity |
| 04/15/1999 | WO1999017769A1 INDENO[1,2-c]-, NAPHTHO[1,2-c]- AND BENZO[6,7]CYCLOHEPTA[1,2-c]PYRAZOLE DERIVATIVES |
| 04/15/1999 | WO1999017765A1 Use of d-methionine to reduce the toxicity of ototoxic drugs, noise, and radiation |
| 04/15/1999 | WO1999017759A2 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 04/15/1999 | WO1999017755A2 Medicaments |
| 04/15/1999 | WO1999017742A2 Taste masked formulations |
| 04/15/1999 | WO1999017612A1 Serotonin containing formulation for oral administration and method of use |
| 04/15/1999 | WO1999009025A3 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor |
| 04/15/1999 | WO1999004773A3 Method for inhibiting bone resorption |
| 04/15/1999 | WO1998055118A3 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases |
| 04/15/1999 | DE19745151A1 New N-2-Mercapto-3-phenyl-propionyl di:peptide derivatives |
| 04/15/1999 | DE19745146A1 New N-acyl N-acyl-aminoethyl alpha-amino acid derivatives |
| 04/15/1999 | CA2308123A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | CA2306273A1 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 04/15/1999 | CA2305805A1 Compounds and methods |
| 04/15/1999 | CA2305751A1 Medicaments |
| 04/15/1999 | CA2305679A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | CA2305190A1 Serotonin containing formulation for oral administration and method of use |
| 04/15/1999 | CA2304826A1 5ht4 agonists and antagonists |
| 04/15/1999 | CA2304630A1 Taste masked formulations |
| 04/15/1999 | CA2304565A1 Indeno[1,2-c]-, naphtho[1,2-c]- and benzo[6,7]cyclohepta[1,2-c]pyrazole derivatives |
| 04/15/1999 | CA2304466A1 Indeno[1,2-c]pyrazole derivatives for inhibiting tyrosine kinase activity |
| 04/15/1999 | CA2304152A1 Novel vitamin d analogues |
| 04/15/1999 | CA2304116A1 Peptide-containing .alpha.-ketoamide cysteine and serine protease inhibitors |
| 04/15/1999 | CA2303449A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/14/1999 | EP0908519A1 Novel glucosaminidase from Staphylococcus aureus |
| 04/14/1999 | EP0908459A1 5-HT4 Agonists and antagonists |
| 04/14/1999 | EP0908456A1 Pyrazole derivatives, their preparation and their use in drugs |
| 04/14/1999 | EP0908169A2 Composition for use as a wound dressing |
| 04/14/1999 | EP0907658A1 Neuropeptide y agonists |
| 04/14/1999 | EP0907632A1 Inhibition of matrix metalloproteases by substituted phenethyl compounds |
| 04/14/1999 | EP0810991B1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists |
| 04/14/1999 | EP0759934B1 Neurotensin antagonist peptides |
| 04/14/1999 | EP0652879B1 1-azaadamantane derivatives as 5-ht4 agonists or antagonists and/or 5-ht3 antagonists |
| 04/14/1999 | EP0595924B1 Platelet activating factor antagonists |
| 04/14/1999 | CN1214046A 4,5-dihydronaphth [1,2-C] isoxazoles and derivatives thereof having CNS activity |
| 04/14/1999 | CN1214043A Benzyl(idene)-lactam derivatives, their prepn. and their use as selective (ant) agaonists of 5-ht1A-and/or 5-ht1D receptors |
| 04/14/1999 | CN1042933C Benzoylguanidine, prepn. of same and application as pharmaceutical and pharmaceutical containing same |
| 04/13/1999 | CA2116799C Solid form xerostomia product |
| 04/13/1999 | CA2005987C Therapeutically active substituted benzimidazole and process for its preparation |
| 04/13/1999 | CA2005547C Derivatives of 1,7' (imidazo-(1,2-a)-pyridine)5'-(6'h)ones |
| 04/09/1999 | CA2246635A1 Novel glucosaminidase |
| 04/08/1999 | WO1999016741A2 Lipophilic diesters of chelating agents |
| 04/08/1999 | WO1999016470A1 Oral preparation |
| 04/08/1999 | WO1999016454A1 Pharmaceutical composition for the treatment of inflammatory bowel disease |
| 04/08/1999 | WO1999016453A1 Method for the treatment of cystic fibrosis |
| 04/08/1999 | WO1999016452A1 THERAPEUTICALLY EFFECTIVE 1α, 25-DIHYDROXYVITAMIN D3 ANALOGS |
| 04/08/1999 | WO1999016436A1 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome |
| 04/08/1999 | CA2305179A1 Oral administration preparation |
| 04/08/1999 | CA2304516A1 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome |
| 04/08/1999 | CA2304482A1 Method for the treatment of cystic fibrosis |
| 04/08/1999 | CA2304056A1 Therapeutically effective 1.alpha., 25-dihydroxyvitamin d3 analogs |
| 04/08/1999 | CA2245924A1 A method of identifying agonists and antagonists for tumor necrosis related receptors tr1, tr3 and tr5 |
| 04/07/1999 | EP0906959A2 Aminopeptidase from Staphylococcus aureus |
| 04/07/1999 | EP0906421A1 Enhanced efficacy of liposomal antisense delivery |
| 04/07/1999 | EP0906338A1 Glucagon-like peptide-2 analogs |
| 04/07/1999 | EP0906315A1 Spiro-piperidine derivatives and their use as therapeutic agents |
| 04/07/1999 | EP0906307A1 Substituted imidazoles having cytokine inhibitory activity |
| 04/07/1999 | EP0906288A1 New compounds |
| 04/07/1999 | EP0906282A1 Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators |
| 04/07/1999 | EP0906273A1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
| 04/07/1999 | EP0906096A1 Agent for inhibiting leukocyte invasion of tissues |
| 04/07/1999 | EP0906091A1 Amidinohydrazones as protease inhibitors |
| 04/07/1999 | EP0906089A2 Buccal delivery system |
| 04/07/1999 | EP0770059B1 Substituted benzamidines, their production and their use as medicaments |
| 04/07/1999 | CN1213372A Heterocycle-condensed morphinoid derivatives (II) |
| 04/07/1999 | CN1213371A 5,11-dihydrodibenz [b,e] [1,4] oxazepine derivatives and drug compositions containing the devivatives |
| 04/07/1999 | CN1213355A Bioactive glass compositions and methods of treatment using bioactive glass |
| 04/07/1999 | CN1213307A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213306A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213305A Novel cycloalkyl substituted imidazolium compounds |
| 04/07/1999 | CN1213303A Method of increasing sphincter competence |